The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

Elijah Cummings

Marathon, under heavy fire for Emflaza pricing, makes surprise deal to sell drug for $140M-plus

Cummings uses Trump drug-price meeting to push Medicare negotiation plan

Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder

Rolling out new importation bill, Sanders, Cummings urge Trump to step up on drug prices

Now, it's Maryland: Pharma pushes back at state-level pricing, transparency bills

Lawmakers decry Army’s planned Zika vaccine license to Sanofi

Congressional pharma critic Cummings hits back after Trump's erratic presser

What innovation? PhRMA slams Marathon after $89K pricing scandal